A study for related factors of in-stent restenosis after coronary stenting in patients with acute coronary syndrome

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900021812

Enrollment

Unknown

Registered

2019-03-11

Start date

2019-04-01

Completion date

Unknown

Last updated

2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome

Interventions

In-stent restenosis group+ non-restenosis group:non

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: From April 2019, the patients, aged 18-80 years, gender is not limited, admitted to Beijing Chaoyang Hospital affiliated to Capital Medical University and diagnosed as acute coronary syndrome (including unstable angina pectoris, acute non-ST-segment elevation myocardial infarction and acute ST-segment elevation myocardial infarction) were performed by coronary angiography and consented to the observational study. Patients were admitted who needed stent implantation after coronary angiography. Informed consent must be signed by the subject.

Exclusion criteria

Exclusion criteria: 1. Pregnant women, lactating women and women of childbearing age who have no safe contraceptive measures; 2. Patients who do not or cannot be implanted after coronary angiography; 3. Patients with acute coronary syndrome caused by non-coronary artery disease; 4. Mechanically-derived complications such as mitral rupture, papillary muscle rupture, atrial septal defect, free wall rupture, ventricular septal defect, and pericardial tamponade; 5. Patients who cannot follow the observations.

Design outcomes

Primary

Measure	Time frame
troponin I/T;Aspartate aminotransferase;Alanine aminotransferase;Electrocardiogram;Plasma exosomes;Plasma microRNA;Coronary angiography;length of the stent;number of the stent;location of the stent;In-stent restenosis;myocardial infarction;death;Malignant arrhythmia;revascularization;	—

Secondary

Measure	Time frame
Blood Pressure;Heart rate;White blood cell;Hemoglobin;Red blood cell;Creatinine;Total cholesterol;Low-density lipoprotein;High-density lipoprotein;Uric acid;Fasting blood sugar;Glycated hemoglobin;Homocysteine;heart failure;	—

Countries

China

Contacts

Public ContactHongjiang Wang

Department of Cardiology, Beijing Chaoyang Hospital, Capital Medical University

wanghongjiang@126.com+86 15810239667

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026